With regards to UNC3’s effects on blood glucose, previous studies in rats and mice, using 90–100 nmol/kg UCN3, have shown reduced glucose tolerance following an OGTT [3–5]; conversely, genetic Ucn3 ablation in mice or antagonism of CRHR2 in rats led to improved glucose tolerance [4, 5]. The gene discussed is UCN3; the disease is glucose measurement.